FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092140172> ?p ?o ?g. }

• W3092140172 abstract "Lung immune prognostic index (LIPI) status was recently developed to predict responses to immune checkpoint inhibitor (ICI) treatments. However, it is unclear whether LIPI is a prognostic index for both patients treated with ICI monotherapy and patients treated with ICIs combined with chemotherapy (ICIs CC).This retrospective study established the patterns of LIPI in Chinese patients with advanced non-small cell lung cancer. Lung immune prognostic index based on the derived neutrophil-to-lymphocyte ratio greater than 3 and lactate dehydrogenase greater than the upper limit of normal was developed to characterize good, intermediate, or poor LIPI status. Associations between LIPI status and progression-free survival (PFS) and overall survival (OS) were analyzed. Kaplan-Meier curves and Cox proportional hazards models were used to determine survival differences.Three hundred thirty patients were included in this study. Of these patients, 216 received ICI monotherapy and 114 received ICIs CC. A good LIPI status was associated with better PFS (6.1 months vs. 2.3 months vs. 2.1 months, P = 0.023) and OS (24.2 months vs. 14.5 months vs. 9.3 months, P < 0.001) in ICI monotherapy compared to intermediate or poor LIPI status. No differences in PFS (17.9 vs. 9.9 months vs. 7.6 months, P = 0.355, respectively) and OS (P = 0.346) were observed in patients who received ICIs CC. Moreover, we found that patients who had an improved LIPI status compared with the baseline value had a longer PFS with ICI monotherapy and LIPI intermediate status (8.4 months vs. 2.1 months vs. 1.4 months, P < 0.001). However, in patients treated with ICIs CC, these dynamic changes were not observed (P = 0.444).Lung immune prognostic index status and dynamic changes in LIPI could be prognostic markers of treatment response to ICI monotherapy, but not to ICIs CC. In particular, good LIPI status was associated with a better clinical outcome compared with intermediate and poor LIPI status in ICI monotherapy treatment." @default.
• W3092140172 created "2020-10-15" @default.
• W3092140172 creator A5000807789 @default.
• W3092140172 creator A5008179879 @default.
• W3092140172 creator A5009635776 @default.
• W3092140172 creator A5032353880 @default.
• W3092140172 creator A5034807554 @default.
• W3092140172 creator A5044991530 @default.
• W3092140172 creator A5053573702 @default.
• W3092140172 creator A5066879163 @default.
• W3092140172 creator A5069498085 @default.
• W3092140172 creator A5079817705 @default.
• W3092140172 creator A5080635647 @default.
• W3092140172 creator A5082489464 @default.
• W3092140172 creator A5085215477 @default.
• W3092140172 date "2020-10-09" @default.
• W3092140172 modified "2023-10-06" @default.
• W3092140172 title "Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer" @default.
• W3092140172 cites W2156353875 @default.
• W3092140172 cites W2157370605 @default.
• W3092140172 cites W2198093519 @default.
• W3092140172 cites W2270932386 @default.
• W3092140172 cites W2276044273 @default.
• W3092140172 cites W2396808887 @default.
• W3092140172 cites W2409418298 @default.
• W3092140172 cites W2527905628 @default.
• W3092140172 cites W2529904548 @default.
• W3092140172 cites W2547825706 @default.
• W3092140172 cites W2557730509 @default.
• W3092140172 cites W2560367415 @default.
• W3092140172 cites W2567564314 @default.
• W3092140172 cites W2572174216 @default.
• W3092140172 cites W2584487585 @default.
• W3092140172 cites W2737656823 @default.
• W3092140172 cites W2747774814 @default.
• W3092140172 cites W2766425839 @default.
• W3092140172 cites W2772599579 @default.
• W3092140172 cites W2775559698 @default.
• W3092140172 cites W2784283849 @default.
• W3092140172 cites W2791483720 @default.
• W3092140172 cites W2792273180 @default.
• W3092140172 cites W2796582438 @default.
• W3092140172 cites W2797744035 @default.
• W3092140172 cites W2799913600 @default.
• W3092140172 cites W2802496191 @default.
• W3092140172 cites W2807965874 @default.
• W3092140172 cites W2888038493 @default.
• W3092140172 cites W2891800461 @default.
• W3092140172 cites W2892640821 @default.
• W3092140172 cites W2916339782 @default.
• W3092140172 cites W2940307933 @default.
• W3092140172 cites W2946386783 @default.
• W3092140172 cites W2951488968 @default.
• W3092140172 cites W2964098540 @default.
• W3092140172 cites W2966695676 @default.
• W3092140172 cites W2978141300 @default.
• W3092140172 cites W2979117438 @default.
• W3092140172 cites W2982017128 @default.
• W3092140172 cites W2987040069 @default.
• W3092140172 cites W2993964118 @default.
• W3092140172 cites W2995533566 @default.
• W3092140172 cites W3010387889 @default.
• W3092140172 doi "https://doi.org/10.3389/fonc.2020.572853" @default.
• W3092140172 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7583465" @default.
• W3092140172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33163403" @default.
• W3092140172 hasPublicationYear "2020" @default.
• W3092140172 type Work @default.
• W3092140172 sameAs 3092140172 @default.
• W3092140172 citedByCount "14" @default.
• W3092140172 countsByYear W30921401722021 @default.
• W3092140172 countsByYear W30921401722022 @default.
• W3092140172 countsByYear W30921401722023 @default.
• W3092140172 crossrefType "journal-article" @default.
• W3092140172 hasAuthorship W3092140172A5000807789 @default.
• W3092140172 hasAuthorship W3092140172A5008179879 @default.
• W3092140172 hasAuthorship W3092140172A5009635776 @default.
• W3092140172 hasAuthorship W3092140172A5032353880 @default.
• W3092140172 hasAuthorship W3092140172A5034807554 @default.
• W3092140172 hasAuthorship W3092140172A5044991530 @default.
• W3092140172 hasAuthorship W3092140172A5053573702 @default.
• W3092140172 hasAuthorship W3092140172A5066879163 @default.
• W3092140172 hasAuthorship W3092140172A5069498085 @default.
• W3092140172 hasAuthorship W3092140172A5079817705 @default.
• W3092140172 hasAuthorship W3092140172A5080635647 @default.
• W3092140172 hasAuthorship W3092140172A5082489464 @default.
• W3092140172 hasAuthorship W3092140172A5085215477 @default.
• W3092140172 hasBestOaLocation W30921401721 @default.
• W3092140172 hasConcept C126322002 @default.
• W3092140172 hasConcept C143998085 @default.
• W3092140172 hasConcept C167135981 @default.
• W3092140172 hasConcept C203014093 @default.
• W3092140172 hasConcept C2776256026 @default.
• W3092140172 hasConcept C2776694085 @default.
• W3092140172 hasConcept C50382708 @default.
• W3092140172 hasConcept C71924100 @default.
• W3092140172 hasConcept C8891405 @default.
• W3092140172 hasConcept C90924648 @default.
• W3092140172 hasConceptScore W3092140172C126322002 @default.
• W3092140172 hasConceptScore W3092140172C143998085 @default.
• W3092140172 hasConceptScore W3092140172C167135981 @default.

• next